Largest pharmaceutical companies in the United States by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 44 pharmaceutical companies in the United States ranked by net assets, at ZAR 1.52T, ahead of Johnson & Johnson (ZAR 1.43T) and Merck & Co (ZAR 922.2B). Figures as of 20 Nov 2026, 05:59 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- PfizerZAR 1.52T
- Median
- ZAR 11.5B
- Combined market value
- ZAR 65.49T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | ZAR 1.52T | ZAR 2.75T | ZAR 482.77 | 1.85% down | 15% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | ZAR 1.43T | ZAR 11.27T | ZAR 4,682.93 | 2.04% down | 34% up | ||
| 3 | Merck & CoMRK · Health Care | ZAR 922.2B | ZAR 5.74T | ZAR 2,328.14 | 3.61% down | 45% up | ||
| 4 | Abbott LaboratoriesABT · Health Care | ZAR 913.8B | ZAR 3.15T | ZAR 1,820.83 | 0.58% down | 16% down | ||
| 5 | Regeneron PharmaceuticalsREGN · Health Care | ZAR 547.9B | ZAR 1.67T | ZAR 16,186.02 | 2.35% down | 28% up | ||
| 6 | Eli LillyLLY · Health Care | ZAR 465.2B | ZAR 21.1T | ZAR 23,684.94 | 2.29% down | 33% up | ||
| 7 | Vertex PharmaceuticalsVRTX · Health Care | ZAR 327.2B | ZAR 2.31T | ZAR 9,127.10 | 2.94% down | 27% up | ||
| 8 | Bristol-Myers SquibbBMY · Health Care | ZAR 323.8B | ZAR 2.09T | ZAR 1,022.69 | 2.05% down | 30% up | ||
| 9 | ViatrisVTRS · Health Care | ZAR 257.9B | ZAR 399.5B | ZAR 348.49 | 1.97% down | 99% up | ||
| 10 | Royalty PharmaRPRX · Health Care | ZAR 170.3B | ZAR 682.6B | ZAR 1,187.12 | 1.38% down | 79% up | ||
| 11 | United TherapeuticsUTHR · Health Care | ZAR 124.4B | ZAR 417.4B | ZAR 9,800.94 | 3.16% down | 22% up | ||
| 12 | Elanco Animal HealthELAN · Health Care | ZAR 114.8B | ZAR 230.4B | ZAR 460.86 | 1.54% down | 26% up | ||
| 13 | BioMarin PharmaceuticalBMRN · Health Care | ZAR 106.7B | ZAR 208.5B | ZAR 1,076.68 | 0.02% down | 17% up | ||
| 14 | ZoetisZTS · Health Care | ZAR 58.4B | ZAR 575.4B | ZAR 1,416.24 | 5.59% down | 26% down | ||
| 15 | Ligand PharmaceuticalsLGND · Health Care | ZAR 17.8B | ZAR 100.6B | ZAR 5,030.02 | 3.94% down | 50% up | ||
| 16 | Legend BiotechLEGN · Health Care | ZAR 17.6B | ZAR 54.7B | ZAR 282.23 | 0.92% down | 41% down | ||
| 17 | Praxis Precision MedicinesPRAX · Health Care | ZAR 15.4B | ZAR 152.3B | ZAR 5,450.03 | 1.87% up | 86% up | ||
| 18 | Alnylam PharmaceuticalsALNY · Health Care | ZAR 13.8B | ZAR 347.1B | ZAR 2,591.26 | 1.06% down | 66% down | ||
| 19 | Belite BioBLTE · Health Care | ZAR 13.5B | ZAR 107.5B | ZAR 2,647.36 | 3.33% down | 43% up | ||
| 20 | InsmedINSM · Health Care | ZAR 13B | ZAR 555.6B | ZAR 2,532.36 | 20.58% up | 40% down | ||
| 21 | Spyre TherapeuticsSYRE · Health Care | ZAR 12.5B | ZAR 162.5B | ZAR 1,711.44 | 3.77% down | 332% up | ||
| 22 | Summit TherapeuticsSMMT · Health Care | ZAR 11.5B | ZAR 148.2B | ZAR 185.29 | 0.67% up | 36% down | ||
| 23 | TG TherapeuticsTGTX · Health Care | ZAR 11.4B | ZAR 171.9B | ZAR 1,137.34 | 1.88% down | 117% up | ||
| 24 | Corcept TherapeuticsCORT · Health Care | ZAR 11.4B | ZAR 124.7B | ZAR 1,139.09 | 4.15% down | 10% down | ||
| 25 | Cogent BiosciencesCOGT · Health Care | ZAR 11.2B | ZAR 84.6B | ZAR 486.28 | 0.25% down | 20% down | ||
| 26 | Protagonist TherapeuticsPTGX · Health Care | ZAR 10.8B | ZAR 141.9B | ZAR 2,174.05 | 2.47% down | 51% up | ||
| 27 | Madrigal PharmaceuticalsMDGL · Health Care | ZAR 10.6B | ZAR 161.6B | ZAR 6,954.80 | 0.34% down | 27% down | ||
| 28 | Edgewise TherapeuticsEWTX · Health Care | ZAR 9.2B | ZAR 79B | ZAR 721.70 | 0.48% down | 86% up | ||
| 29 | Dianthus TherapeuticsDNTH · Health Care | ZAR 8.6B | ZAR 83.7B | ZAR 1,487.06 | 1.01% up | 108% up | ||
| 30 | Ionis PharmaceuticalsIONS · Health Care | ZAR 8.6B | ZAR 79.5B | ZAR 477.16 | 0.62% down | 63% down | ||
| 31 | Oruka TherapeuticsORKA · Health Care | ZAR 8.3B | ZAR 116B | ZAR 1,710.39 | 1.91% up | 255% up | ||
| 32 | Arrowhead PharmaceuticalsARWR · Health Care | ZAR 8.2B | ZAR 108.2B | ZAR 765.18 | 1.25% up | 13% up | ||
| 33 | Definium TherapeuticsDFTX · Health Care | ZAR 5.8B | ZAR 70.7B | ZAR 516.78 | 1.24% up | 168% up | ||
| 34 | ErascaERAS · Health Care | ZAR 5.7B | ZAR 87.5B | ZAR 249.27 | 3.34% up | 395% up | ||
| 35 | Mirum PharmaceuticalsMIRM · Health Care | ZAR 5.5B | ZAR 109.3B | ZAR 1,674.28 | 3.27% up | 34% up | ||
| 36 | Rhythm PharmaceuticalsRYTM · Health Care | ZAR 2.4B | ZAR 142B | ZAR 2,047.49 | 1.88% down | 18% up | ||
| 37 | Travere TherapeuticsTVTX · Health Care | ZAR 2B | ZAR 81.3B | ZAR 846.69 | 3.86% down | 45% up | ||
| 38 | Axsome TherapeuticsAXSM · Health Care | ZAR 1.5B | ZAR 125.1B | ZAR 2,378.45 | 1.25% up | 6% down | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | -ZAR 1.2B | ZAR 130.6B | ZAR 374.96 | 2.24% down | 90% up | ||
| 40 | VeradermicsMANE · Health Care | -ZAR 2.1B | ZAR 92B | ZAR 2,180.54 | 0.38% down | 231% up | ||
| 41 | PTC TherapeuticsPTCT · Health Care | -ZAR 3.6B | ZAR 85.4B | ZAR 1,022.43 | 3.16% down | 21% down | ||
| 42 | CytokineticsCYTK · Health Care | -ZAR 11.6B | ZAR 125.7B | ZAR 902.09 | 0.27% up | 19% down | ||
| 43 | BridgeBio PharmaBBIO · Health Care | -ZAR 36.6B | ZAR 267B | ZAR 1,370.48 | 0.22% up | 21% up | ||
| 44 | AbbVieABBV · Health Care | -ZAR 57.3B | ZAR 8.79T | ZAR 4,970.42 | 0.86% down | 25% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 17.5299 ZAR).
Questions and answers
Which pharmaceutical companies in the United States rank first by net assets?
Pfizer (ZAR 1.52T), Johnson & Johnson (ZAR 1.43T) and Merck & Co (ZAR 922.2B) are the top three of the 44 pharmaceutical companies in the United States ranked by net assets as of 20 Nov 2026, 05:59 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by net assets.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by net assets have a combined market value of ZAR 65.49T as of 20 Nov 2026, 05:59 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by net assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.